{"id":"69155398-1ff7-4269-bf81-07819e1668d9","kind":"institutions","code":"UB-I2068","name":"Hualangufen","nameBasis":"transliterated","summary":"Hualan (301093), a pharmaceutical sealing components company investing strategically across the pharmaceutical value chain.","description":"Hualan (301093), a pharmaceutical sealing components company investing strategically across the pharmaceutical value chain.","country":null,"category":null,"originalName":"华兰股份","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:04:21.109Z","englishUpdatedAt":"2026-10-15T21:37:02.686Z","reviewedAt":"2026-10-15T21:37:02.686Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"10b215495b779ba435d3860bc3bffa0ef82f8ee9ee7412a40c8f481a28f1e909","companyId":null,"foundedYear":null,"logoUrl":null,"originalText":"华兰股份（301093），药用密封组件企业，围绕医药产业链战略投资。","sources":[],"related":[{"id":"94c7cccb-8114-4192-92e5-85ac4fa4145f","kind":"news","code":"94c7cccb-8114-4192-92e5-85ac4fa4145f","name":"Clickmab completes seed financing","nameBasis":"translated-title","summary":"On 2026-01-19, according to Xiniu Data, Clickmab completed seed financing for an undisclosed amount. Investors were Jingtai Technology, Hualangufen, Xi Venture Capital.","description":"","country":null,"category":null,"originalName":"科迈生物完成种子轮融资","eventDate":"2026-01-19T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-15T12:42:31.304Z","englishUpdatedAt":"2026-10-15T20:50:22.117Z","reviewedAt":"2026-10-15T20:50:22.117Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"8d81137f25c24ad1881f39451ea2136f00da3ecf22aef5f07b087ab3765610d5","companyId":"8df9793f-c638-441d-9e1e-a876ef3ea74b","foundedYear":null,"logoUrl":null,"path":"/news/94c7cccb-8114-4192-92e5-85ac4fa4145f"},{"id":"80fcbbdb-2f2b-4145-83a7-6e7f36a575b6","kind":"news","code":"80fcbbdb-2f2b-4145-83a7-6e7f36a575b6","name":"Clickmab raises RMB 20 million in equity financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"科迈生物完成2000万元股权投资融资","eventDate":"2025-11-14T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-10T18:51:48.803Z","englishUpdatedAt":"2026-10-15T17:19:59.685Z","reviewedAt":"2026-10-15T17:19:59.685Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"eb8179ce72661938f43663b9da3c3849f1ed5895ecc91f15faadbc25a94aa26d","companyId":"8df9793f-c638-441d-9e1e-a876ef3ea74b","foundedYear":null,"logoUrl":null,"path":"/news/80fcbbdb-2f2b-4145-83a7-6e7f36a575b6"},{"id":"af60f951-ead9-4aaf-b6db-903326f8b995","kind":"news","code":"af60f951-ead9-4aaf-b6db-903326f8b995","name":"Ziranchangshu raises RMB 200 million in angel financing","nameBasis":"translated-title","summary":"On 2026-06-02, according to Xiniu Data, Ziranchangshu completed angel financing, raising RMB 200 million. Investors were lead investor Hualangufen, participating investor Hete Energy, participating investor Zhejiang Litao. The company is a provider of AI drug research and development decision services.","description":"","country":null,"category":null,"originalName":"自然常数完成天使轮融资，金额2亿人民币","eventDate":"2026-06-02T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-15T17:08:17.020Z","englishUpdatedAt":"2026-10-15T19:55:31.801Z","reviewedAt":"2026-10-15T19:55:31.801Z","snapshotAt":"2026-10-15T18:31:34.288Z","sourceHash":"7f1d094b89310a8a559309ae9c54e31909d42b1b1deb12cc0c9a70959b777e4e","companyId":"d227493c-45f1-485d-b430-9bd89f64ad2b","foundedYear":null,"logoUrl":null,"path":"/news/af60f951-ead9-4aaf-b6db-903326f8b995"}],"path":"/institutions/hualangufen","canonical":"https://uniquebase.ai/institutions/hualangufen"}